Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis-Reference-Cited by-同舟云学术

Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis

Published:2006-02 Issue:2 Volume:51 Page:181-191
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tang Jian-Min,He Quan-Ying,Guo Rui-Xia,Chang Xiu-Jun

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. American cancer society surveillance research. Cancer facts and figures 2004. Atlanta (GA): American cancer society; 2004:1–60.

2. The phosphatidylinositol 3-kinase AKT pathway in human cancer;Vivanco;Nat Rev Cancer,2002

3. Akt/protein kinase B is constitutively active in non-small cell lung cancer and promotes cellular survival and resistance to chemotherapy and radiation;Brognard;Cancer Res,2001

4. Protein kinase B(c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation;Coffer;Biochem J,1998

5. New insights into tumor suppression: PTEN suppression tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway;Cantley;PNAS,1999

Cited by 287 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the potential therapeutic targets and mechanisms of jaranol for the treatment of COVID-19 and lung adenocarcinoma;Arabian Journal of Chemistry;2024-03

2. Impact of Dysregulated LINC01559 and LINC01410 Expression on the Diagnosis and Survival of Non-Small Cell Lung Cancer;Biochemical Genetics;2024-01-24

3. Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives;Cells;2023-08-07

4. p-mTOR, p-ERK and PTEN Expression in Tumor Biopsies and Organoids as Predictive Biomarkers for Patients with HPV Negative Head and Neck Cancer;Head and Neck Pathology;2023-07-24

5. Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma;Biomedicine & Pharmacotherapy;2023-05